EWA
IOVA icon

EverSource Wealth Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

EverSource Wealth Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.22K Buy
2,058
+1,526
+287% +$4.88K ﹤0.01% 3087
2025
Q4 		$1.45K Sell
532
-5
-0.9% -$12 ﹤0.01% 3605
2025
Q3 		$1.17K Sell
537
-117
-18% -$276 ﹤0.01% 3720
2025
Q2 		$1.13K Buy
654
+150
+30% +$373 ﹤0.01% 3701
2025
Q1 		$1.68K Buy
504
+367
+268% +$1.89K ﹤0.01% 3004
2024
Q4 		$1.01K Sell
137
-4,222
-97% -$39.1K ﹤0.01% 2959
2024
Q3 		$40.9K Sell
4,359
-2,250
-34% -$21.3K ﹤0.01% 1145
2024
Q2 		$57.7K Buy
+6,609
New +$70.8K ﹤0.01% 1024
2023
Q3 		– Sell
-228
Closed -$1.6K – 2590
2023
Q2 		$1.6K Buy
+228
New +$1.63K ﹤0.01% 2089

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return